<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>Purpose: To test the hypothesis that miR-205 plays a key role instimulation of growth factors release, TGFA and EGF, in woundedcorneal epithelial cell by targeting 3-UTR of KCNJ10, therebyinhibiting the K channel activity which leads to Ca2+ influx andactivating EGFR/ERK phosphorylation.Methods: The expression level of miR-205 and KCNJ10 wereexamined by stem-loop qRT-PCR and western blot in cultured HCEcells. The wound-healing assay was used to examine the recoveryrate of HCE cells. TGFA and EGF in the media, an index as growthfactor secreted by HCE, were measured by ELISA. We used dualluciferase activity as a report gene to assess the effect of miR-205 onKCNJ10 expression. To study the role of miR-205 and KCNJ10 inregulation of HCE function, the HCE cells were transfected withmiR-205 mimic or KCNJ10 siRNA. The patch-clamp technique wasused to measure the K currents in HCE cells.Results: Mechanic scratching HCE cells stimulated the expression ofmiR-205 by 50% within 1 hour and decreased the expression ofKCNJ10 within 24 hours. Application of miR-205 antagomersignificantly delayed the healing process of HCE, an effect waspartially revered by inhibiting K channels with BaCl2. Moreover,inhibition of kcnj10 channels with shRNA also partially restored thedelayed healing by miR-205 antagomer. The possibility that increasein miR-205 in wounded HCE cells facilitates the cell regeneration byinhibiting inward rectifier K channels was also confirmed by thefinding that miR-205 decreased luciferase report gene activity in cellstransfected with 3’UTR of KCNJ10. Moreover, Western blot andpatch-clamp experiments demonstrated that suppression of theendogenous mir-205 expression enhanced the expression in KCNJ10but not KCNJ16 in plasma membrane and inward K currents in HCEcells by 150%. The possibility that inhibition of K channels by miR-205 may stimulate growth factor release through a depolarizationinducedCa2+ signaling is also suggested by the finding thatinhibition of KCNJ10 by siRNA increased TGFA/EGF release intomedia through upregulation of EGFR/ERK pathway.Conclusions: We conclude that miR-205 is one of the importantfactors stimulating healing of wounded HCE cell by inhibitingKCNJ10 inwardly-rectifying K channels thereby enhancingTGFA/EGF release and facilitating the repair process.Commercial Relationships: Daohong Lin, None; Adna Halilovic,None; Sherin Thomas, None; Kemeng Wang, None; Peng Yue,None; Lars Bellner, NoneSupport: AHA 11SDG7360052Program Number: 3866 Poster Board Number: D0110Presentation Time: 2:45 PM - 4:30 PMEffects of In-vivo Application of Cold Atmospheric Plasma on<strong>Cornea</strong>l Wound Healing in New Zealand White RabbitsRashed Alhabshan 1 , David Belyea 1 , Mary Ann Stepp 1, 2 , JeffreyBarratt 1 , Sanjeev Grewal 1 , Alexey Shashurin 3 , Michael Keidar 3 .1 Department of Ophthalmology, George Washington University,Washington, DC; 2 Department of Anatomy and RegenerativeBiology, George Washington University, Washington, DC;3 Department of Mechanical and Aerospace Engineering, GeorgeWashington University, Washington, DC.Purpose: Cold Atmospheric Plasma (CAP) has been shown to reducecorneal infection but little is known about the impact of CAP onhealthy corneal tissues and their ability to respond to injuries. Toexamine the effect of Cold Atmospheric Plasma (CAP) on woundhealing after corneal epithelial and basement membrane ablation inNew Zealand white rabbits.Methods: Twelve New Zealand white rabbits were assigned into twogroups, Group A (7 rabbits) and Group B (5 rabbits). Five rabbitsfrom each group underwent surgical intervention to the right eye, a 6mm central corneal ablation to the epithelium and stroma using anAlger brush with 0.5 mm burr. After ablation, all rabbits in group Areceived 120s application of CAP. Two rabbits in Group A receivedCAP application without ablation. Eyes monitored for haze,inflammation, and reepithelialization with slit lamp examination. 24hours after ablation, two corneas were harvested from each group.The 20th day, the remaining corneas were harvested, fixed informalin and stained with H&E. In addition, immunofluorescencemicroscopy was performed to assess scar formation using antibodiesagainst fibronectin and αsmooth muscle actin.Results: <strong>Cornea</strong>l reepithelialization on day 1 showed that rabbits ingroup A (treated) had an average epithelial defect of 9.25 mm2 andgroup B (untreated) had a defect of 12.05 mm2, not a statisticallysignificant difference. H & E stained sections showed the expectedresponses of stromal fibroblasts to debridement injury in both groups.Epithelial thickness and stromal cell counts on both groups 20 daysafter injury showed no significant statistical differences. At 24 hoursand 20 days after injury, analyses show that CAP-treatment increasedfibronectin deposition in the anterior stroma and αSMA localizationwithin stromal fibroblasts; quantitative analysis ofimmunofluorescence data will be needed to determine whether thesedifferences are significant.Conclusions: CAP treatment following corneal injury does notinterfere with rate of wound closure or induce increasedinflammation. CAP treatment did affect corneal tissues since αSMAand fibronectin localization within stromal fibroblasts appears toincrease slightly after CAP treatment regardless of whether corneashave been wounded. More studies are needed to evaluate thepotential effects of CAP on the cornea and its possible applications inthe field of Ophthalmology.Commercial Relationships: Rashed Alhabshan, None; DavidBelyea, None; Mary Ann Stepp, None; Jeffrey Barratt, None;Sanjeev Grewal, None; Alexey Shashurin, None; Michael Keidar,NoneSupport: "GWU MFA Award"; "NIH RO1 EY08512 to MAS"; "TheMansour F Armaly Glaucoma Research Fund (fund # ET11161)"Program Number: 3867 Poster Board Number: D0111Presentation Time: 2:45 PM - 4:30 PM<strong>Cornea</strong>l optical density during Hyperbaric Oxygen TherapyKnut Evanger 1 , Guro Vaagbø 2 , Einar Thorsen 2, 3 , Olav H. Haugen 1, 4 .1 Institute of Clinical Medicine, University of Bergen, Bergen,Norway; 2 Hyperbaric Medicine Unit, Dept. of OccupationalMedicine, Haukeland University Hospital, Bergen, Norway; 3 Instituteof Medicine, University of Bergen, Bergen, Norway; 4 Department ofOphthalmology, Haukeland University Hospital, Bergen, Norway.Purpose: To evaluate the influence of hyperbaric oxygen therapy onthe anterior corneal optical density and the refractive index. Little isknown about the effect on the anterior corneal surface when the eyeis exposed to enhanced oxygen concentration and pressure.Methods: 16 patients (32 eyes) were receiving 100% oxygen at apressure of 240 kPa in a monoplace chamber for 90 min daily.Anterior corneal optical density was measured with the densitometryprogram of the Pentacam Scheimpflug imaging system (OculusOptikgeräte GmbH) at baseline and repeated after completed 19 daysof treatment. The 180-degree rotating Scheimpflug camera capturesoptical density data according to the light scattering intensity of theanterior cornea. The density measurement values are standardizedfrom 0 (no clouding) to 100 (tissue completely opaque). TheGladstone-Dale constant was calculated at baseline by using theGladestone-Dale formula, the mean anterior corneal optical densityvalue, and a refractive index of 1.376 of the normal human cornea.Results: Mean anterior corneal optical density and refractive index©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>were 26.05 ± 1.48 and 1.376 (normal human cornea) at baseline, and26.43 ± 1.48 and 1.381 ± 0.02 after 19 days of treatment (p < 0.15).The resultant Gladestone-Dale constant was 0.014. No change incorneal transparency was revealed by the biomicroscope slitlamp.Conclusions: No significant change in anterior corneal opticaldensity and refractive index were present after the hyperbaric oxygentherapy, only a small increase from baseline appeared.Commercial Relationships: Knut Evanger, None; Guro Vaagbø,None; Einar Thorsen, None; Olav H. Haugen, NoneClinical Trial: Project no: 3.2009.736Program Number: 3868 Poster Board Number: D0112Presentation Time: 2:45 PM - 4:30 PMOsteo-odonto-keratoprosthesis (OOKP) and the testing of threedifferent adhesives for bonding bovine teeth with optical PMMAcylinderKristin Weisshuhn 1 , Isabelle Berg 2 , Daniel Tinner 3 , Christoph Kunz 2 ,Michael M. Bornstein 4 , Markus Steineck 5 , Konrad Hille 6 , DavidGoldblum 1 . 1 Ophthalmology, University Hospital Basel, Basel,Switzerland; 2 Maxillofacial Surgery, University Hospital Basel,Basel, Switzerland; 3 Practice of Dentistry and Reconstruction, Basel,Switzerland; 4 Oral Surgery and Stomatology, School of DentalMedicine, University Bern, Bern, Switzerland; 5 Dentistry, UniversityBasel, Basel, Switzerland; 6 Ophthalmology, Ortenau ClinicOffenburg, Offenburg, Germany.Purpose: The preparation of the lamina in osteo-odontokeratoprosthesis(OOKP) is complex and its longevity and watertightness important. Until now only acrylic bone cements have beenused for bonding the optical cylinder into the dentin of the tooth. Ouraim was to evaluate different dental adhesives for OOKPpreparations.Methods: Specimens of bovine teeth were produced by preparing 1.5mm thick slices with holes of 3.5 mm in diameter in the dentin of thetooth. Every group (n=10 per group) was luted with a differentadhesive: Classic Poly-(Methyl Methacrylat) bone cement, auniversal resin cement and a glass ionomer cement. Every specimenof each group underwent force measurement completed with auniaxial traction machine.Results: The highest mean force was measured for Poly-(MethylMethacrylat) bone cement (128.2 N), followed by universal resincement (127.9 N) with no statistically significant difference. Glassionomer cement showed significant lower force values (78.1 N).Conclusions: Excellent bond strength combined with the easyapplication was found for universal resin cement, which mightbecome an alternative to acrylic bone cement in preparing an OOKP.Commercial Relationships: Kristin Weisshuhn, None; IsabelleBerg, None; Daniel Tinner, None; Christoph Kunz, None; MichaelM. Bornstein, None; Markus Steineck, None; Konrad Hille, None;David Goldblum, NoneProgram Number: 3869 Poster Board Number: D0113Presentation Time: 2:45 PM - 4:30 PMDifference in ocular damage by 40 and 95 GHz exposure torabbit eyeMasami Kojima 1, 2 , Nailia Hasanova 1 , Hiroshi Sasaki 1 , KazuyukiSasaki 1 . 1 Vis Res for Environmtl Hlth/Med Res Inst, Kanazawa MedUniv, Kahoku, Japan; 2 Medical Chemistry, Nursing school ofKanazawa Medical University, Kahoku, Japan.Purpose: Millimeter waves (MMW) are prevalent in high-speedwireless communication, automobile collision prevention systemsand high-resolution radar imaging. We examined frequency (40 and95 GHz) dependent differences of corneal damage in rabbit eye.Methods: Pigmented rabbits (N=48, Dutch, 13-16 week-old) wereexposed unilaterally to 95 GHz MMW at 200 mW/cm 2 for 6 or 10minutes, and 40 GHz MMW at 200, 300, 400 mW/cm 2 for 6 min bylens antenna. Systemic anesthesia during exposure and ocularexamination was induced by medetomidine hydrochloride (0.5mg/kg). Ocular changes were evaluated by slit-lamp. <strong>Cornea</strong>l surfacetemperature during exposure was recorded by thermograph camera(R300, NEC Avio). Microencapsulated thermochromic liquid crystal(MTLC) injected into the anterior chamber prior to exposure withcolor change recorded by video camera during exposure revealedheat transport.Results: <strong>Cornea</strong>l surface temperature following 95 GHz 200mW/cm 2 , 6 and 10 min exposure was 42.6±2.1 degrees Celsius (C)and 43.2±1.3 degrees C, respectively (NS). Representative oculardamage were diffuse corneal epithelial cell damage immediately afterexposure, corneal epithelial defect and corneal edema 1 day afterexposure. Exposure for 10 min caused more severe cornealepithelium defect (12/12 eyes) than for 6 min (4/7 eyes). Maximumcorneal surface temperatures by 40 GHz at 200, 300 and 400mW/cm 2 were 41.4±1.1, 42.5±1.1, and 45.5±2.1 degrees C,respectively. Exposure for 6 min to 40 GHz at 200 mW/cm 2 causedtransient corneal diffuse damage (3/6 eyes) and at 300 mW/cm 2diffuse corneal epithelial damage (6/6 eyes). Diffuse cornealepithelial cell damage occurred immediately following exposure at400 mW/cm 2 (3/5 eyes), and corneal epithelial defect (2/4 eyes) andcorneal edema (2/4) 1 day after. Morphological evaluation showed 95GHz at 200 mW/cm 2 and 40 GHz at 400 mW/cm 2 , for 6 min, causedsimilar damage. <strong>Cornea</strong>l surface penetration depth of 40 and 95 GHzwas 0.59 and 0.31 mm, respectively. MTLC analysis revealed that 40GHz exposure transported heat to iris and lens by aqueous humorconvection within 20 sec, compared to 60 sec by 95 GHz (Fig).Conclusions: Ocular heat effects by 40 and 95 GHz MMW differedwith 95 GHz being more severe. MMW penetration depth, heattransport, and dissipation from cornea play important roles in oculardamage.Aqueous humor convection by 40 or 95 GHz exposureCommercial Relationships: Masami Kojima, None; NailiaHasanova, None; Hiroshi Sasaki, None; Kazuyuki Sasaki, NoneSupport: The Committee to Promote Research on the PotentialBiological Effects of Electromagnetic Fields, Ministry of InternalAffairs and Communications, JapanProgram Number: 3870 Poster Board Number: D0114Presentation Time: 2:45 PM - 4:30 PMRetinoids improvements during the treatment by humanamniotic membrane of corneal alkali burns in a mouse modelNicolas Bonnin 1, 2 , Loic Blanchon 2 , Corinne Belville 2, 3 , GeorgesSouteyrand 1 , Frederic Chiambaretta 1, 2 , Vincent Sapin 2 .1 Ophthalmology, Gabriel Montpied Hospital, Clermont-Ferrand,France; 2 R2D2 EA7281, Auvergne University, Clermont-Ferrand,©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the <strong>ARVO</strong> Office at arvo@arvo.org.
- Page 2 and 3:
ARVO 2013 Annual Meeting Abstracts
- Page 4 and 5:
ARVO 2013 Annual Meeting Abstracts
- Page 6 and 7:
ARVO 2013 Annual Meeting Abstracts
- Page 8 and 9:
ARVO 2013 Annual Meeting Abstracts
- Page 10:
ARVO 2013 Annual Meeting Abstracts
- Page 13 and 14:
ARVO 2013 Annual Meeting Abstracts
- Page 16 and 17:
ARVO 2013 Annual Meeting Abstracts
- Page 18 and 19:
ARVO 2013 Annual Meeting Abstracts
- Page 20 and 21:
ARVO 2013 Annual Meeting Abstracts
- Page 22 and 23:
ARVO 2013 Annual Meeting Abstracts
- Page 24 and 25:
ARVO 2013 Annual Meeting Abstracts
- Page 26 and 27:
ARVO 2013 Annual Meeting Abstracts
- Page 28 and 29:
ARVO 2013 Annual Meeting Abstracts
- Page 30 and 31:
ARVO 2013 Annual Meeting Abstracts
- Page 32 and 33:
ARVO 2013 Annual Meeting Abstracts
- Page 34 and 35:
ARVO 2013 Annual Meeting Abstracts
- Page 36 and 37:
ARVO 2013 Annual Meeting Abstracts
- Page 38 and 39:
ARVO 2013 Annual Meeting Abstracts
- Page 40 and 41:
ARVO 2013 Annual Meeting Abstracts
- Page 42 and 43:
ARVO 2013 Annual Meeting Abstracts
- Page 44 and 45:
ARVO 2013 Annual Meeting Abstracts
- Page 46 and 47:
ARVO 2013 Annual Meeting Abstracts
- Page 48 and 49:
ARVO 2013 Annual Meeting Abstracts
- Page 50 and 51:
ARVO 2013 Annual Meeting Abstracts
- Page 52 and 53:
ARVO 2013 Annual Meeting Abstracts
- Page 54 and 55:
ARVO 2013 Annual Meeting Abstracts
- Page 56 and 57:
ARVO 2013 Annual Meeting Abstracts
- Page 58 and 59:
ARVO 2013 Annual Meeting Abstracts
- Page 60 and 61:
ARVO 2013 Annual Meeting Abstracts
- Page 62 and 63:
ARVO 2013 Annual Meeting Abstracts
- Page 64 and 65:
ARVO 2013 Annual Meeting Abstracts
- Page 66 and 67:
ARVO 2013 Annual Meeting Abstracts
- Page 68 and 69:
ARVO 2013 Annual Meeting Abstracts
- Page 70 and 71:
ARVO 2013 Annual Meeting Abstracts
- Page 72 and 73:
ARVO 2013 Annual Meeting Abstracts
- Page 74 and 75:
ARVO 2013 Annual Meeting Abstracts
- Page 76 and 77:
ARVO 2013 Annual Meeting Abstracts
- Page 78 and 79:
ARVO 2013 Annual Meeting Abstracts
- Page 80 and 81:
ARVO 2013 Annual Meeting Abstracts
- Page 82 and 83:
ARVO 2013 Annual Meeting Abstracts
- Page 84 and 85:
ARVO 2013 Annual Meeting Abstracts
- Page 86 and 87:
ARVO 2013 Annual Meeting Abstracts
- Page 88 and 89:
ARVO 2013 Annual Meeting Abstracts
- Page 90 and 91:
ARVO 2013 Annual Meeting Abstracts
- Page 92 and 93:
ARVO 2013 Annual Meeting Abstracts
- Page 94 and 95:
ARVO 2013 Annual Meeting Abstracts
- Page 96 and 97:
ARVO 2013 Annual Meeting Abstracts
- Page 98 and 99:
ARVO 2013 Annual Meeting Abstracts
- Page 100 and 101:
ARVO 2013 Annual Meeting Abstracts
- Page 102 and 103:
ARVO 2013 Annual Meeting Abstracts
- Page 104 and 105:
ARVO 2013 Annual Meeting Abstracts
- Page 106 and 107:
ARVO 2013 Annual Meeting Abstracts
- Page 108 and 109:
ARVO 2013 Annual Meeting Abstracts
- Page 110 and 111:
ARVO 2013 Annual Meeting Abstracts
- Page 112 and 113:
ARVO 2013 Annual Meeting Abstracts
- Page 114 and 115:
ARVO 2013 Annual Meeting Abstracts
- Page 116 and 117:
ARVO 2013 Annual Meeting Abstracts
- Page 118 and 119:
ARVO 2013 Annual Meeting Abstracts
- Page 120 and 121:
ARVO 2013 Annual Meeting Abstracts
- Page 122 and 123:
ARVO 2013 Annual Meeting Abstracts
- Page 124 and 125:
ARVO 2013 Annual Meeting Abstracts
- Page 126 and 127:
ARVO 2013 Annual Meeting Abstracts
- Page 128 and 129:
ARVO 2013 Annual Meeting Abstracts
- Page 130 and 131:
ARVO 2013 Annual Meeting Abstracts
- Page 132 and 133:
ARVO 2013 Annual Meeting Abstracts
- Page 134 and 135:
ARVO 2013 Annual Meeting Abstracts
- Page 136 and 137:
ARVO 2013 Annual Meeting Abstracts
- Page 138 and 139:
ARVO 2013 Annual Meeting Abstracts
- Page 140 and 141:
ARVO 2013 Annual Meeting Abstracts
- Page 142 and 143:
ARVO 2013 Annual Meeting Abstracts
- Page 144 and 145:
ARVO 2013 Annual Meeting Abstracts
- Page 146 and 147:
ARVO 2013 Annual Meeting Abstracts
- Page 148 and 149:
ARVO 2013 Annual Meeting Abstracts
- Page 150 and 151:
ARVO 2013 Annual Meeting Abstracts
- Page 152 and 153:
ARVO 2013 Annual Meeting Abstracts
- Page 154 and 155:
ARVO 2013 Annual Meeting Abstracts
- Page 156 and 157:
ARVO 2013 Annual Meeting Abstracts
- Page 158 and 159:
ARVO 2013 Annual Meeting Abstracts
- Page 160 and 161:
ARVO 2013 Annual Meeting Abstracts
- Page 162 and 163:
ARVO 2013 Annual Meeting Abstracts
- Page 164 and 165:
ARVO 2013 Annual Meeting Abstracts
- Page 166 and 167:
ARVO 2013 Annual Meeting Abstracts
- Page 168 and 169:
ARVO 2013 Annual Meeting Abstracts
- Page 170 and 171:
ARVO 2013 Annual Meeting Abstracts
- Page 172 and 173:
ARVO 2013 Annual Meeting Abstracts
- Page 174 and 175:
ARVO 2013 Annual Meeting Abstracts
- Page 176 and 177:
ARVO 2013 Annual Meeting Abstracts
- Page 178 and 179:
ARVO 2013 Annual Meeting Abstracts
- Page 180 and 181:
ARVO 2013 Annual Meeting Abstracts
- Page 182 and 183:
ARVO 2013 Annual Meeting Abstracts
- Page 184 and 185:
ARVO 2013 Annual Meeting Abstracts
- Page 186 and 187:
ARVO 2013 Annual Meeting Abstracts
- Page 188 and 189: ARVO 2013 Annual Meeting Abstracts
- Page 190 and 191: ARVO 2013 Annual Meeting Abstracts
- Page 192 and 193: ARVO 2013 Annual Meeting Abstracts
- Page 194 and 195: ARVO 2013 Annual Meeting Abstracts
- Page 196 and 197: ARVO 2013 Annual Meeting Abstracts
- Page 198 and 199: ARVO 2013 Annual Meeting Abstracts
- Page 200 and 201: ARVO 2013 Annual Meeting Abstracts
- Page 202 and 203: ARVO 2013 Annual Meeting Abstracts
- Page 204 and 205: ARVO 2013 Annual Meeting Abstracts
- Page 206 and 207: ARVO 2013 Annual Meeting Abstracts
- Page 208 and 209: ARVO 2013 Annual Meeting Abstracts
- Page 210 and 211: ARVO 2013 Annual Meeting Abstracts
- Page 212 and 213: ARVO 2013 Annual Meeting Abstracts
- Page 214 and 215: ARVO 2013 Annual Meeting Abstracts
- Page 216 and 217: ARVO 2013 Annual Meeting Abstracts
- Page 218 and 219: ARVO 2013 Annual Meeting Abstracts
- Page 220 and 221: ARVO 2013 Annual Meeting Abstracts
- Page 222 and 223: ARVO 2013 Annual Meeting Abstracts
- Page 224 and 225: ARVO 2013 Annual Meeting Abstracts
- Page 226 and 227: ARVO 2013 Annual Meeting Abstracts
- Page 228 and 229: ARVO 2013 Annual Meeting Abstracts
- Page 230 and 231: ARVO 2013 Annual Meeting Abstracts
- Page 232 and 233: ARVO 2013 Annual Meeting Abstracts
- Page 234 and 235: ARVO 2013 Annual Meeting Abstracts
- Page 236 and 237: ARVO 2013 Annual Meeting Abstracts
- Page 240 and 241: ARVO 2013 Annual Meeting Abstracts
- Page 242 and 243: ARVO 2013 Annual Meeting Abstracts
- Page 244 and 245: ARVO 2013 Annual Meeting Abstracts
- Page 246 and 247: ARVO 2013 Annual Meeting Abstracts
- Page 248 and 249: ARVO 2013 Annual Meeting Abstracts
- Page 250 and 251: ARVO 2013 Annual Meeting Abstracts
- Page 252 and 253: ARVO 2013 Annual Meeting Abstracts
- Page 254 and 255: ARVO 2013 Annual Meeting Abstracts
- Page 256 and 257: ARVO 2013 Annual Meeting Abstracts
- Page 258 and 259: ARVO 2013 Annual Meeting Abstracts
- Page 260 and 261: ARVO 2013 Annual Meeting Abstracts
- Page 262 and 263: ARVO 2013 Annual Meeting Abstracts
- Page 264 and 265: ARVO 2013 Annual Meeting Abstracts
- Page 266 and 267: ARVO 2013 Annual Meeting Abstracts
- Page 268 and 269: ARVO 2013 Annual Meeting Abstracts
- Page 270 and 271: ARVO 2013 Annual Meeting Abstracts
- Page 272 and 273: ARVO 2013 Annual Meeting Abstracts
- Page 274 and 275: ARVO 2013 Annual Meeting Abstracts
- Page 276 and 277: ARVO 2013 Annual Meeting Abstracts
- Page 278 and 279: ARVO 2013 Annual Meeting Abstracts
- Page 280 and 281: ARVO 2013 Annual Meeting Abstracts
- Page 282 and 283: ARVO 2013 Annual Meeting Abstracts
- Page 284 and 285: ARVO 2013 Annual Meeting Abstracts
- Page 286 and 287: ARVO 2013 Annual Meeting Abstracts
- Page 288 and 289:
ARVO 2013 Annual Meeting Abstracts
- Page 290 and 291:
ARVO 2013 Annual Meeting Abstracts
- Page 292 and 293:
ARVO 2013 Annual Meeting Abstracts
- Page 294 and 295:
ARVO 2013 Annual Meeting Abstracts
- Page 296 and 297:
ARVO 2013 Annual Meeting Abstracts
- Page 298 and 299:
ARVO 2013 Annual Meeting Abstracts
- Page 300 and 301:
ARVO 2013 Annual Meeting Abstracts
- Page 302 and 303:
ARVO 2013 Annual Meeting Abstracts
- Page 304 and 305:
ARVO 2013 Annual Meeting Abstracts
- Page 306 and 307:
ARVO 2013 Annual Meeting Abstracts
- Page 308 and 309:
ARVO 2013 Annual Meeting Abstracts
- Page 310 and 311:
ARVO 2013 Annual Meeting Abstracts
- Page 312 and 313:
ARVO 2013 Annual Meeting Abstracts
- Page 314 and 315:
ARVO 2013 Annual Meeting Abstracts
- Page 316 and 317:
ARVO 2013 Annual Meeting Abstracts
- Page 318 and 319:
ARVO 2013 Annual Meeting Abstracts
- Page 320 and 321:
ARVO 2013 Annual Meeting Abstracts
- Page 322 and 323:
ARVO 2013 Annual Meeting Abstracts
- Page 324 and 325:
ARVO 2013 Annual Meeting Abstracts
- Page 326 and 327:
ARVO 2013 Annual Meeting Abstracts
- Page 328 and 329:
ARVO 2013 Annual Meeting Abstracts
- Page 330 and 331:
ARVO 2013 Annual Meeting Abstracts
- Page 332 and 333:
ARVO 2013 Annual Meeting Abstracts
- Page 334 and 335:
ARVO 2013 Annual Meeting Abstracts
- Page 336 and 337:
ARVO 2013 Annual Meeting Abstracts
- Page 338 and 339:
ARVO 2013 Annual Meeting Abstracts
- Page 340 and 341:
ARVO 2013 Annual Meeting Abstracts
- Page 342 and 343:
ARVO 2013 Annual Meeting Abstracts
- Page 344 and 345:
ARVO 2013 Annual Meeting Abstracts
- Page 346 and 347:
ARVO 2013 Annual Meeting Abstracts
- Page 348 and 349:
ARVO 2013 Annual Meeting Abstracts
- Page 350 and 351:
ARVO 2013 Annual Meeting Abstracts
- Page 352 and 353:
ARVO 2013 Annual Meeting Abstracts
- Page 354 and 355:
ARVO 2013 Annual Meeting Abstracts
- Page 356 and 357:
ARVO 2013 Annual Meeting Abstracts
- Page 358 and 359:
ARVO 2013 Annual Meeting Abstracts
- Page 360 and 361:
ARVO 2013 Annual Meeting Abstracts
- Page 362 and 363:
ARVO 2013 Annual Meeting Abstracts
- Page 364 and 365:
ARVO 2013 Annual Meeting Abstracts
- Page 366 and 367:
ARVO 2013 Annual Meeting Abstracts
- Page 368 and 369:
ARVO 2013 Annual Meeting Abstracts
- Page 370 and 371:
ARVO 2013 Annual Meeting Abstracts
- Page 372 and 373:
ARVO 2013 Annual Meeting Abstracts
- Page 374 and 375:
ARVO 2013 Annual Meeting Abstracts
- Page 376 and 377:
ARVO 2013 Annual Meeting Abstracts
- Page 378 and 379:
ARVO 2013 Annual Meeting Abstracts
- Page 380 and 381:
ARVO 2013 Annual Meeting Abstracts
- Page 382 and 383:
ARVO 2013 Annual Meeting Abstracts